Review



human normal gastric epithelial cell line (ges1  (Procell Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Procell Inc human normal gastric epithelial cell line (ges1
    Human Normal Gastric Epithelial Cell Line (Ges1, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human normal gastric epithelial cell line (ges1/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    human normal gastric epithelial cell line (ges1 - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    98
    ATCC normal human gastric epithelial cell line ges1
    G protein pathway suppressor 2 (GPS2) is expressed at low levels in gastric cancer (GC) and low GC expression is associated with poor prognosis. A, Western blot analysis of the GPS2 protein levels in the <t>GES1</t> and GC cell lines. B, Determination of the GPS2 mRNA levels in 16 tumor tissues and paired noncancerous normal tissues from GC patients by quantitative PCR. ∆Ct (N), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in normal gastric tissues. ∆Ct (T), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in the cancer tissues. The bar value (∆Ct (N) – ∆Ct (T)) represents the difference in the GPS2 mRNA levels between the normal tissues and paired tumor tissues. Bar value = −1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 −1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is decreased in the tumors. Bar value = 1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is increased in the tumors. C, Western blot analyses of GPS2 protein expression in 10 tumor tissues (T) and paired noncancerous normal tissues (N) from GC patients (P#1‐P#10). D, Immunohistochemical (IHC) analysis of the GPS2 protein levels in GC tissues and normal tissues on a tissue microarray. GC tissue sections were quantitatively scored according to the percentage of positive cells and staining intensity. E, Representative images of IHC staining of GPS2 protein expression in normal tissues and two different GC tissues. F, IHC analysis of GPS2 protein levels in 30 paired GC tissues. G, Relative proportion of GC patients with low GPS2 expression in T, N, and clinical stages. H, Survival curves of GC patients with low GPS2 expression vs GC patients with high GPS2 expression. * P < .05; *** P < .001
    Normal Human Gastric Epithelial Cell Line Ges1, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/normal human gastric epithelial cell line ges1/product/ATCC
    Average 98 stars, based on 1 article reviews
    normal human gastric epithelial cell line ges1 - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    90
    Procell Inc human normal gastric epithelial cell line (ges1
    G protein pathway suppressor 2 (GPS2) is expressed at low levels in gastric cancer (GC) and low GC expression is associated with poor prognosis. A, Western blot analysis of the GPS2 protein levels in the <t>GES1</t> and GC cell lines. B, Determination of the GPS2 mRNA levels in 16 tumor tissues and paired noncancerous normal tissues from GC patients by quantitative PCR. ∆Ct (N), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in normal gastric tissues. ∆Ct (T), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in the cancer tissues. The bar value (∆Ct (N) – ∆Ct (T)) represents the difference in the GPS2 mRNA levels between the normal tissues and paired tumor tissues. Bar value = −1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 −1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is decreased in the tumors. Bar value = 1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is increased in the tumors. C, Western blot analyses of GPS2 protein expression in 10 tumor tissues (T) and paired noncancerous normal tissues (N) from GC patients (P#1‐P#10). D, Immunohistochemical (IHC) analysis of the GPS2 protein levels in GC tissues and normal tissues on a tissue microarray. GC tissue sections were quantitatively scored according to the percentage of positive cells and staining intensity. E, Representative images of IHC staining of GPS2 protein expression in normal tissues and two different GC tissues. F, IHC analysis of GPS2 protein levels in 30 paired GC tissues. G, Relative proportion of GC patients with low GPS2 expression in T, N, and clinical stages. H, Survival curves of GC patients with low GPS2 expression vs GC patients with high GPS2 expression. * P < .05; *** P < .001
    Human Normal Gastric Epithelial Cell Line (Ges1, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human normal gastric epithelial cell line (ges1/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    human normal gastric epithelial cell line (ges1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Procell Inc human normal gastric epithelial cell line (ges1)
    G protein pathway suppressor 2 (GPS2) is expressed at low levels in gastric cancer (GC) and low GC expression is associated with poor prognosis. A, Western blot analysis of the GPS2 protein levels in the <t>GES1</t> and GC cell lines. B, Determination of the GPS2 mRNA levels in 16 tumor tissues and paired noncancerous normal tissues from GC patients by quantitative PCR. ∆Ct (N), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in normal gastric tissues. ∆Ct (T), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in the cancer tissues. The bar value (∆Ct (N) – ∆Ct (T)) represents the difference in the GPS2 mRNA levels between the normal tissues and paired tumor tissues. Bar value = −1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 −1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is decreased in the tumors. Bar value = 1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is increased in the tumors. C, Western blot analyses of GPS2 protein expression in 10 tumor tissues (T) and paired noncancerous normal tissues (N) from GC patients (P#1‐P#10). D, Immunohistochemical (IHC) analysis of the GPS2 protein levels in GC tissues and normal tissues on a tissue microarray. GC tissue sections were quantitatively scored according to the percentage of positive cells and staining intensity. E, Representative images of IHC staining of GPS2 protein expression in normal tissues and two different GC tissues. F, IHC analysis of GPS2 protein levels in 30 paired GC tissues. G, Relative proportion of GC patients with low GPS2 expression in T, N, and clinical stages. H, Survival curves of GC patients with low GPS2 expression vs GC patients with high GPS2 expression. * P < .05; *** P < .001
    Human Normal Gastric Epithelial Cell Line (Ges1), supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human normal gastric epithelial cell line (ges1)/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    human normal gastric epithelial cell line (ges1) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Procell Inc normal human gastric epithelial cell line ges1 cl-0563
    G protein pathway suppressor 2 (GPS2) is expressed at low levels in gastric cancer (GC) and low GC expression is associated with poor prognosis. A, Western blot analysis of the GPS2 protein levels in the <t>GES1</t> and GC cell lines. B, Determination of the GPS2 mRNA levels in 16 tumor tissues and paired noncancerous normal tissues from GC patients by quantitative PCR. ∆Ct (N), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in normal gastric tissues. ∆Ct (T), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in the cancer tissues. The bar value (∆Ct (N) – ∆Ct (T)) represents the difference in the GPS2 mRNA levels between the normal tissues and paired tumor tissues. Bar value = −1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 −1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is decreased in the tumors. Bar value = 1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is increased in the tumors. C, Western blot analyses of GPS2 protein expression in 10 tumor tissues (T) and paired noncancerous normal tissues (N) from GC patients (P#1‐P#10). D, Immunohistochemical (IHC) analysis of the GPS2 protein levels in GC tissues and normal tissues on a tissue microarray. GC tissue sections were quantitatively scored according to the percentage of positive cells and staining intensity. E, Representative images of IHC staining of GPS2 protein expression in normal tissues and two different GC tissues. F, IHC analysis of GPS2 protein levels in 30 paired GC tissues. G, Relative proportion of GC patients with low GPS2 expression in T, N, and clinical stages. H, Survival curves of GC patients with low GPS2 expression vs GC patients with high GPS2 expression. * P < .05; *** P < .001
    Normal Human Gastric Epithelial Cell Line Ges1 Cl 0563, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/normal human gastric epithelial cell line ges1 cl-0563/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    normal human gastric epithelial cell line ges1 cl-0563 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Procell Inc normal human gastric mucosal epithelial cell line ges1
    G protein pathway suppressor 2 (GPS2) is expressed at low levels in gastric cancer (GC) and low GC expression is associated with poor prognosis. A, Western blot analysis of the GPS2 protein levels in the <t>GES1</t> and GC cell lines. B, Determination of the GPS2 mRNA levels in 16 tumor tissues and paired noncancerous normal tissues from GC patients by quantitative PCR. ∆Ct (N), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in normal gastric tissues. ∆Ct (T), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in the cancer tissues. The bar value (∆Ct (N) – ∆Ct (T)) represents the difference in the GPS2 mRNA levels between the normal tissues and paired tumor tissues. Bar value = −1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 −1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is decreased in the tumors. Bar value = 1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is increased in the tumors. C, Western blot analyses of GPS2 protein expression in 10 tumor tissues (T) and paired noncancerous normal tissues (N) from GC patients (P#1‐P#10). D, Immunohistochemical (IHC) analysis of the GPS2 protein levels in GC tissues and normal tissues on a tissue microarray. GC tissue sections were quantitatively scored according to the percentage of positive cells and staining intensity. E, Representative images of IHC staining of GPS2 protein expression in normal tissues and two different GC tissues. F, IHC analysis of GPS2 protein levels in 30 paired GC tissues. G, Relative proportion of GC patients with low GPS2 expression in T, N, and clinical stages. H, Survival curves of GC patients with low GPS2 expression vs GC patients with high GPS2 expression. * P < .05; *** P < .001
    Normal Human Gastric Mucosal Epithelial Cell Line Ges1, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/normal human gastric mucosal epithelial cell line ges1/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    normal human gastric mucosal epithelial cell line ges1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    99
    ATCC human normal gastric mucosal epithelial cell line ges1
    G protein pathway suppressor 2 (GPS2) is expressed at low levels in gastric cancer (GC) and low GC expression is associated with poor prognosis. A, Western blot analysis of the GPS2 protein levels in the <t>GES1</t> and GC cell lines. B, Determination of the GPS2 mRNA levels in 16 tumor tissues and paired noncancerous normal tissues from GC patients by quantitative PCR. ∆Ct (N), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in normal gastric tissues. ∆Ct (T), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in the cancer tissues. The bar value (∆Ct (N) – ∆Ct (T)) represents the difference in the GPS2 mRNA levels between the normal tissues and paired tumor tissues. Bar value = −1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 −1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is decreased in the tumors. Bar value = 1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is increased in the tumors. C, Western blot analyses of GPS2 protein expression in 10 tumor tissues (T) and paired noncancerous normal tissues (N) from GC patients (P#1‐P#10). D, Immunohistochemical (IHC) analysis of the GPS2 protein levels in GC tissues and normal tissues on a tissue microarray. GC tissue sections were quantitatively scored according to the percentage of positive cells and staining intensity. E, Representative images of IHC staining of GPS2 protein expression in normal tissues and two different GC tissues. F, IHC analysis of GPS2 protein levels in 30 paired GC tissues. G, Relative proportion of GC patients with low GPS2 expression in T, N, and clinical stages. H, Survival curves of GC patients with low GPS2 expression vs GC patients with high GPS2 expression. * P < .05; *** P < .001
    Human Normal Gastric Mucosal Epithelial Cell Line Ges1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human normal gastric mucosal epithelial cell line ges1/product/ATCC
    Average 99 stars, based on 1 article reviews
    human normal gastric mucosal epithelial cell line ges1 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    G protein pathway suppressor 2 (GPS2) is expressed at low levels in gastric cancer (GC) and low GC expression is associated with poor prognosis. A, Western blot analysis of the GPS2 protein levels in the GES1 and GC cell lines. B, Determination of the GPS2 mRNA levels in 16 tumor tissues and paired noncancerous normal tissues from GC patients by quantitative PCR. ∆Ct (N), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in normal gastric tissues. ∆Ct (T), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in the cancer tissues. The bar value (∆Ct (N) – ∆Ct (T)) represents the difference in the GPS2 mRNA levels between the normal tissues and paired tumor tissues. Bar value = −1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 −1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is decreased in the tumors. Bar value = 1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is increased in the tumors. C, Western blot analyses of GPS2 protein expression in 10 tumor tissues (T) and paired noncancerous normal tissues (N) from GC patients (P#1‐P#10). D, Immunohistochemical (IHC) analysis of the GPS2 protein levels in GC tissues and normal tissues on a tissue microarray. GC tissue sections were quantitatively scored according to the percentage of positive cells and staining intensity. E, Representative images of IHC staining of GPS2 protein expression in normal tissues and two different GC tissues. F, IHC analysis of GPS2 protein levels in 30 paired GC tissues. G, Relative proportion of GC patients with low GPS2 expression in T, N, and clinical stages. H, Survival curves of GC patients with low GPS2 expression vs GC patients with high GPS2 expression. * P < .05; *** P < .001

    Journal: Cancer Science

    Article Title: G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptor

    doi: 10.1111/cas.15151

    Figure Lengend Snippet: G protein pathway suppressor 2 (GPS2) is expressed at low levels in gastric cancer (GC) and low GC expression is associated with poor prognosis. A, Western blot analysis of the GPS2 protein levels in the GES1 and GC cell lines. B, Determination of the GPS2 mRNA levels in 16 tumor tissues and paired noncancerous normal tissues from GC patients by quantitative PCR. ∆Ct (N), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in normal gastric tissues. ∆Ct (T), the Ct value of GAPDH was subtracted from the Ct value of GPS2 in the cancer tissues. The bar value (∆Ct (N) – ∆Ct (T)) represents the difference in the GPS2 mRNA levels between the normal tissues and paired tumor tissues. Bar value = −1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 −1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is decreased in the tumors. Bar value = 1 indicates that the GPS2 mRNA expression of the tumor tissues is 2 1 ‐fold of that of the paired normal tissues, showing that the expression of GPS2 is increased in the tumors. C, Western blot analyses of GPS2 protein expression in 10 tumor tissues (T) and paired noncancerous normal tissues (N) from GC patients (P#1‐P#10). D, Immunohistochemical (IHC) analysis of the GPS2 protein levels in GC tissues and normal tissues on a tissue microarray. GC tissue sections were quantitatively scored according to the percentage of positive cells and staining intensity. E, Representative images of IHC staining of GPS2 protein expression in normal tissues and two different GC tissues. F, IHC analysis of GPS2 protein levels in 30 paired GC tissues. G, Relative proportion of GC patients with low GPS2 expression in T, N, and clinical stages. H, Survival curves of GC patients with low GPS2 expression vs GC patients with high GPS2 expression. * P < .05; *** P < .001

    Article Snippet: The GC lines MKN74, SGC7901, BGC823, MGC803, HGC27, and AGS and normal human gastric epithelial cell line GES1 were purchased from ATCC.

    Techniques: Expressing, Western Blot, Real-time Polymerase Chain Reaction, Immunohistochemical staining, Microarray, Staining, Immunohistochemistry